Conversio Health Recalls Albuterol and Budesonide Vials Due to Processing Controls
Conversio Health is recalling Albuterol 2.5mg / Budesonide 0.5mg inhalation vials nationwide due to a lack of processing controls.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically corresponds to a Moderate severity score when no specific injuries or illnesses are reported in the source text.
Plain-English summary
Integrated Health Concepts Inc. dba Conversio Health is recalling Albuterol 2.5mg / Budesonide 0.5mg, 3ML Vials, For Inhalation Only. The recall was initiated because of a lack of processing controls. The affected product is distributed nationwide in the U.S., and all lots are included in this recall.
Consumers who have this product should stop using it and contact the recalling firm for further instructions. The FDA has classified this recall as Class II, indicating a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Albuterol 2.5mg / Budesonide 0.5mg, 3ML Vial, For Inhalation Only, Shake Well, Conversio Health, San Luis Obispo, CA 93401.
- Category
- Drug — Inhalation Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Integrated Health Concepts Inc. dba Conversio Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Integrated Health Concepts Inc. dba Conversio Health
See all →- ModerateConversio Health Recalls Budesonide Inhalation Vials Due to Processing Control Issues
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Inhalation Vials
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Vials Due to Processing Controls
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Vials Due to Processing Controls
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Inhalation Vials
FDA (Drugs) · 2019-11-27
Same hazard · processing controls
See all →- HighCompounded tirzepatide 8.8 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 11.24 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.22 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.44 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 4.4 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13